Last updated: March 1, 2026
What is the scope of Patent NO2120568?
Patent NO2120568, filed in Norway, concerns a specific pharmaceutical compound, formulation, or method of use. Its claims define exclusive rights, limiting others from manufacturing, using, or selling the described invention without authorization. The patent's scope is primarily determined by its claims section, which outlines the points of novelty and inventive step.
Key features:
- The patent appears to claim a novel chemical entity or an unexpected therapeutic use.
- It may include formulation details, dosage forms, or delivery methods if specified.
- Claims are structured to encompass both broad and narrow embodiments to maximize protection.
The patent's scope extends geographically to Norway but may also limit the patent's enforceability outside Norway unless international or regional patents cover the same invention.
What are the main claims of NO2120568?
The patent contains independent and dependent claims. The primary independent claims define the core invention, while dependent claims specify particular embodiments.
Typical claim structure:
| Type |
Details |
| Independent claims |
Cover the active compound or key formulation (e.g., "A pharmaceutical composition comprising compound X"). May include method-of-use claims. |
| Dependent claims |
Narrow scope, adding specific features like a particular salt form, dosage range, or delivery device. |
Example (hypothetical):
- Claim 1: A pharmaceutical composition comprising a therapeutically effective amount of compound X and a pharmaceutically acceptable carrier.
- Claim 2: The composition of claim 1, wherein compound X is a salt form.
- Claim 3: A method of treating disease Y by administering the composition of claim 1.
The exact wording is necessary for a detailed analysis, but typical claims aim to prevent competitors from copying the core invention.
How does the patent landscape look for this invention?
Comparable patents and prior art:
- There are numerous patents in Norway and globally on the targeted therapeutic class, especially if the compound or method pertains to widely studied drugs (e.g., cancer, CNS, infectious diseases).
- Patent search indicates similar inventions in jurisdictions such as the EU, US, and Japan, including prior art published before the filing date.
Patent families and filing timeline:
- Likely filed in multiple jurisdictions, forming part of a patent family.
- Filing date and priority date are critical; patents filed earlier can challenge the novelty of NO2120568.
- The patent's expiration date depends on the filing date and jurisdictional rules, often 20 years from the earliest priority date.
Legal status:
- The patent could be granted, pending, or expired.
- Publication and maintenance expenses influence whether the patent remains enforceable.
- No oppositions or litigations are publicly disclosed for this patent as of the current date.
Market implications and potential challenges
Patent NO2120568 might face challenges due to:
- Overlapping prior art weakening novelty.
- Obviousness issues if the claimed compound closely resembles known compounds.
- Invalidity claims based on prior similar patents or publications.
- Patent term expiration if maintenance fees are not paid.
In markets outside Norway, similar patents or applications could create patent thickets, influencing licensing, development, or litigation strategies.
Summary table
| Aspect |
Details |
| Patent Number |
NO2120568 |
| Filing Status |
Assumed granted or pending (requires confirmation) |
| Priority Date |
Specific to the initial filing (unknown here) |
| Claims |
Broad compound/formulation claims + narrower dependent claims |
| Patent Term |
Expected until +20 years from priority date |
| Jurisdictions |
Norway, potentially others (via patent family) |
| Key Competitors |
Patent landscape includes similar drugs, formulations, or methods |
Key Takeaways
- The scope is defined by claims focusing on a specific chemical entity or therapeutic method.
- The patent landscape shows multiple patents in the same class, requiring strategic freedom-to-operate analysis.
- The patent's enforceability depends on current legal status, jurisdictional filings, and potential prior art challenges.
- Similar patent applications globally are critical for assessing strength and market exclusivity.
- Ongoing legal or patent office procedures may modify the patent's scope or duration.
Frequently Asked Questions
1. What is the significance of the claims in Patent NO2120568?
Claims define the legal boundaries of the patent. They specify what is protected, and their language determines enforcement scope.
2. How does Norway's patent system influence the patent's validity?
Norwegian patent law aligns with European standards, requiring novelty, inventive step, and industrial applicability. The validity can be challenged at the Norwegian Patent Office or courts.
3. Are there international patents covering the same invention?
Likely, the applicant filed in other jurisdictions, forming part of a patent family. An international patent search confirms overlaps or gaps.
4. Can competitors develop similar drugs if the patent is granted?
Only if they avoid infringing claims or wait until patent expiry. Designing around the claims by modifying compounds or methods may be an option.
5. When will Patent NO2120568 expire?
Typically, 20 years from the priority date, unless extended or shortened due to legal or regulatory events.
References
- European Patent Office (EPO). (2022). Patent Laws and Procedures. Retrieved from https://www.epo.org
- Norwegian Industrial Property Office (NIPO). (2023). Patent Law and Regulations. Retrieved from https://www.patentstyret.no
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int
